Positive results from AELIX’ HIV therapeutic vaccine clinical study published in Nature Medicine
ABL and Imugene partner to advance oncolytic virus candidate towards later phase clinical trials
admed laboratory adopts QuantaMatrix dRAST solution in routine clinical use
Immunotherapy: Tollys presents new data at OTS 2022, demonstrating anti-tumor activity of TL-532
PDC*line Pharma presents first clinical results from Phase I/II trial with PDC*lung01 at ESMO 2022
Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy
Diabetes: AdipoPharma’s first-in-class candidate – PATAS – shows improvement in whole-body insulin resistance and associated comorbidities in vivo
Naobios delivers FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials
